Ted
Abel, Ph.D.
Professor,
Dept of Biology
319 Leidy Labs
(215) 898-5614 FAX: (215) 898-8780
email: abele@sas.upenn.edu
http://www.bio.upenn.edu/faculty/abel/
Click here for selected publications since Dr. Abel's arrival at Penn
RESEARCH INTERESTSThe molecular basis of synaptic plasticity, learning and memory; the molecular basis of sleep/wake regulation
RESEARCH TECHNIQUES
Creation and analysis of genetically modified mice; behavioral assays of
learning and memory; electrophysiological recordings from hippocampal neurons;
EEG and EMG recording from awake mice
RESEARCH SUMMARY
Synaptic plasticity, the change in the strength of neuronal connections
in the brain, is thought to underlie memory storage and may play a crucial
role in a variety of neurological and mental disorders, including mental
retardation, Alzheimer's disease and depression. One goal of our research
is to use transgenic mice to explore the molecular basis of synaptic plasticity
and memory storage. Transgenic techniques can be used to express gene products
designed to inhibit or enhance the activity of endogenous signaling pathways
with a high degree of molecular specificity. The transgenic approach is
spatially and temporally more restricted than the conventional gene knockout
approach, thereby allowing for a more direct correlation between a behavioral
deficit and synaptic physiology in the adult brain. Recently, we have extended
our studies of genetically modified mice to examine the role of specific
signal transduction pathways in sleep/wake regulation.
The Molecular Basis of Long-Term Memory Storage
One form of synaptic plasticity that has received much attention is long-term
potentiation (LTP), an activity-dependent form of synaptic enhancement.
Like many forms of memory and synaptic plasticity, LTP in the hippocampus
has distinct temporal phases. Long-lasting LTP (L-LTP) differs from the
early phase of LTP in requiring protein kinase A (PKA) activity, protein
synthesis and transcription. To explore the molecular basis and behavioral
significance of long-lasting forms of synaptic plasticity, we have produced
mice in which PKA activity in the hippocampus is reduced by the transgenic
expression of R(AB), a dominant negative form of the regulatory subunit
of PKA. R(AB) transgenic mice exhibit selective impairments in long-term
contextual memory and long-lasting forms of hippocampal LTP. These long-term
memory impairments are paralleled at the systems level by a long-term
instability of place cells in R(AB) transgenic mice. We have also used
these R(AB) transgenic mice to explore the molecular basis of the trial
spacing effect at the electrophysiological and behavioral level. Spaced
training is generally more effective than massed training for learning
and memory, and our experiments suggest that enhanced memory following
spaced training is particularly sensitive to protein synthesis and PKA
inhibition.
The critical molecular targets of PKA and the identity of genes whose
expression is regulated by this signal transduction pathway during memory
storage remain crucial open questions, and R(AB) transgenic animals provide
a physiological system in which to define the molecular events that are
downstream from PKA activation. These biochemical and molecular studies
will examine the PKA targets CREB and protein phosphatase inhibitor-1
and investigate the role of PKA in gene induction following learning.
This induction of gene expression may be mediated by PKA and CREB as well
as by the transcriptional coactivator and histone acetyltransferase CREB
binding protein (CBP). To explore the spatial and temporal patterns of
activation of the transcription factor CREB, we have constructed a novel
chimeric transcription factor, tTA-CREB, which combines the DNA binding
domain of a mammalianized and optimized tetracycline sensitive transactivator
with the activation domains of CREB. By expressing this chimeric transcription
factor in transgenic mice in combination with appropriate tetracycline-responsive
reporter genes, we are attempting to monitor reporter gene induction repeatedly
and non-invasively using molecular imaging approaches.
One of the challenges in the study of signal transduction pathways in
neurons is to understand the way in which signals are restricted to subcellular
compartments and how different signaling pathways interact. To explore
these issues, we are investigating the role of A kinase anchoring proteins
(AKAPs) in learning and synaptic plasticity. AKAPs localize PKA to specific
subcellular locations and assemble PKA into signaling modules that include
phosphodiesterases, phosphatases, ion channels and receptors. A truncated
form of one AKAP, Ht31, has been used as an inhibitor capable of blocking
the interactions between PKA and other AKAPs. To study the role of PKA
localization via interactions with AKAPs in learning and memory, we have
generated conditional transgenic mice expressing a truncated form of Ht31
in neurons within the forebrain using the CaMKIIa
promoter and the tetracycline regulatory system. We are examining learning
and memory as well as synaptic plasticity in these transgenic mice to
characterize the role of A kinase anchoring in hippocampal and amygdala
function.
Spatial and Temporal Regulation of Transgene Expression
Inducible systems are crucial for determining if the phenotype observed
in adult animals is due to acute expression of the transgene or due to an
indirect effect of the transgene on developmental processes. Such regulation
may be achieved by combining regionally restricted promoters with the tetracycline-responsive
system. We have developed new lines of transgenic mice in which expression
of the R(AB) transgene is temporally, quantitatively and spatially regulated
to define precisely the role that PKA plays in memory acquisition, consolidation,
and retrieval. We are developing promoters that drive expression of transgenes
in restricted regions of the brain, so that behavioral deficits may be assigned
unambiguously to such defined brain structures as individual subfields within
the hippocampus. In terms of synaptic plasticity, this approach will allow
us to determine whether the transgene is acting pre- or postsynaptically.
By using inducible systems to express transgenes that enhance the cAMP/PKA
system, we are exploring whether long-term memory can be improved by increasing
signaling through the PKA pathway. Because of the slow time course of the
tetracycline-responsive system, we are exploring the use of mutated steroid
hormone binding domains as well as the use of heterologous receptor systems
to rapidly regulate the cAMP/PKA signal transduction pathway.
Molecular Mechanisms of Extinction
Many molecular accounts of long-term memory storage postulate that the
synthesis of new proteins is necessary for long-term changes in neuronal
function. These experiments generally have examined the learning that
occurs as associations are acquired between neutral and biologically important
stimuli. Little is known about the importance of protein synthesis in
the establishment of memories for extinction, which occurs as the relations
established during acquisition are severed. We have found that although
memories for the acquisition of spatial and contextual learning required
protein synthesis, memories for extinction formed in the absence of protein
synthesis. These results suggest that acquisition and extinction are mediated
by distinct molecular mechanisms and that long-term memories can form
in the absence of protein synthesis. An important question is to determine
the molecular mechanisms that underlie the long-term behavioral changes
that occur during extinction, and experiments are in progress to explore
this question.
Mouse Models of Endophenotypes of Psychiatric Disorders
Recent evidence suggests that disturbances in intracellular signaling
may contribute to schizophrenia. Studies in humans indicate that activity
within the cyclic AMP/protein kinase A (cAMP/PKA) signaling pathway may
be upregulated in the central nervous systems of schizophrenia patients.
Schizophrenia patients exhibit several fundamental cognitive and neurobehavioral
dysfunctions (endophenotypes) that can be objectively measured and quantified
for the purposes of experimental analysis. Two such endophenotypes are
inhibitory gating deficits and explicit learning impairments. These endophenotypes
represent basic information processing disturbances that may contribute
to the profound cognitive disturbances and thought disorders evident in
schizophrenia. Because these endophenotypes can be readily modeled in
laboratory animals, they serve as critical windows for elucidating the
neurobiological basis for abnormal information processing in schizophrenia.
We have found that transgenic mice overexpressing a constitutively active
form of the signaling protein Gsa
(Gsa*) in forebrain
neurons exhibit deficits in animal models of inhibitory gating and explicit
learning. We are currently investigating whether these deficits can be
reversed by treatment with antipsychotics and whether antipsychotics can
rescue the spatial learning deficits in these transgenics.
CREB and Sleep/Wake Regulation
Although much is known about the neural systems and neurotransmitters that
regulate sleep and wakefulness, studies of the molecular regulation of sleep/wake
states are only beginning to identify key molecules in intracellular signaling
pathways that control these processes. The cyclic AMP-response element binding
protein (CREB) is an activity-dependent transcription factor important for
synaptic plasticity and memory storage. In rodents, levels of phosphorylated
CREB within the cortex are higher in waking than in sleep, suggesting that
CREB may play a role in sleep/wake regulation in mammals. Our studies of
sleep/wake states in mice lacking the a and D isoforms of Creb demonstrate
that CREB acts to promote wakefulness. Over a 24-hour period, wake was significantly
decreased in CrebaD
mutant mice by approximately 100 minutes, and time spent in non-rapid eye
movement (NREM) sleep was correspondingly increased. This decrease in wakefulness
was largely due to an inability of Creb mutant mice to maintain the
longer periods of wakefulness that occur during the nocturnal active period.
CrebaD mice
had decreased levels of theta activity during wake and REM sleep, suggesting
that CREB plays a critical role in cortical arousal. Our data, together
with that from studies of Drosophila, indicate that there are molecular
mechanisms that promote wakefulness, possibly driven by wake-active neurotransmitters,
such as norepinephrine. Indeed, norepinephrine can function to activate
CREB. We hypothesize that CREB activity is normally altered by state-related
changes in neural function; in turn, a suite of genes is activated by CREB
and these genes subserve the functions of waking. We are identifying the
targets of CREB important for sleep/wake regulation by analyzing knockout
mice lacking the CREB target genes such as bdnf or zif268
and by carrying out gene expression studies.
KEY WORDS:
Memory storage; synaptic plasticity; long-term potentiation; behavior; genetically modified mice, sleep-wake regulation
|